INCR
INC Research Holdings Inc
NASDAQ: INCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.81
-6.38% today
Updated 2026-04-29
Market cap
$49.15M
P/E ratio
—
P/S ratio
0.55x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
INC Research Holdings Inc (INCR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.23M | $12.07M | $8.47M | $8.25M | $5.65M | $1.40M | — | $0.00 | $0.00 | $8.93M | $65.03M | $219.68M | $388.68M | $355.55M | $238.84M |
| Revenue growth (YoY) | — | -8.8% | -29.8% | -2.6% | -31.5% | -75.2% | -100.0% | — | — | — | +628.6% | +237.8% | +76.9% | -8.5% | -32.8% |
| Cost of revenue | $3.13M | $2.89M | $2.00M | $1.84M | $1.87M | $538705.00 | — | $0.00 | — | $7.45M | $33.06M | $128.55M | $233.60M | $250.46M | $208.61M |
| Gross profit | $10.10M | $9.18M | $6.47M | $6.41M | $3.78M | $862708.00 | — | $0.00 | — | $1.48M | $31.98M | $91.13M | $155.08M | $105.09M | $30.23M |
| Gross margin | 76.3% | 76.0% | 76.4% | 77.7% | 66.8% | 61.6% | — | — | — | 16.6% | 49.2% | 41.5% | 39.9% | 29.6% | 12.7% |
| R&D | $1.03M | $844932.00 | $351178.00 | $104475.00 | $50621.00 | — | — | — | — | $1.71M | $1.58M | $1.24M | $632000.00 | $388000.00 | $414000.00 |
| SG&A | $8.59M | $5.17M | $4.52M | $2.89M | $3.17M | $2.02M | $1.40M | $1.12M | $9.81M | $79.27M | $20.43M | $45.30M | $91.72M | $64.30M | $62.92M |
| Operating income | $-5.00M | $-1.80M | $-2.17M | $-1.94M | $-2.67M | $-2.51M | $1.20M | $-3.98M | $-10.62M | $-3.42M | $-38.40M | $28.19M | $50.63M | $-41.57M | $-67.21M |
| Operating margin | -37.8% | -14.9% | -25.7% | -23.5% | -47.3% | -179.2% | — | — | — | -38.3% | -59.0% | 12.8% | 13.0% | -11.7% | -28.1% |
| EBITDA | $-3.21M | $544258.00 | $45.38M | $-6.38M | $-3.77M | $-1.64M | $-1.07M | $-1.09M | $-10.12M | $-3.77M | $-34.53M | $31.17M | $70.23M | $-23.90M | $-51.31M |
| EBITDA margin | -24.3% | 4.5% | 535.9% | -77.3% | -66.7% | -117.1% | — | — | — | -42.2% | -53.1% | 14.2% | 18.1% | -6.7% | -21.5% |
| EBIT | $-3.71M | $319704.00 | $45.27M | $-6.52M | $-3.79M | $-1.64M | $1.20M | $-1.09M | $-10.13M | $-4.59M | $-37.78M | $23.78M | $58.53M | $-37.07M | $-66.68M |
| Interest expense | $8.81M | $7.08M | $1.83M | $86690.00 | $109000.00 | $206893.00 | $411586.00 | $639510.00 | $1.03M | $1.97M | $528000.00 | $5.04M | $14.69M | $24.22M | $20.64M |
| Income tax | $46123.00 | $41866.00 | $1.83M | $87062.00 | $0.00 | $-781000.00 | $3.05M | $663839.00 | $-1.15M | $-673000.00 | $-2.27M | $11.44M | $93000.00 | $2.25M | $-14.53M |
| Effective tax rate | -0.4% | -0.6% | 4.0% | -1.3% | 0.0% | 29.4% | 92.0% | -14.4% | 8.2% | 10.2% | 5.7% | 70.9% | 0.2% | -3.8% | 17.6% |
| Net income | $-12.56M | $-6.80M | $43.44M | $-6.61M | $-3.79M | $-1.88M | $265415.00 | $-5.26M | $-12.80M | $-5.89M | $-37.23M | $4.69M | $44.82M | $-61.96M | $-67.80M |
| Net income growth (YoY) | — | +45.9% | +738.8% | -115.2% | +42.6% | +50.5% | +114.1% | -2081.4% | -143.4% | +54.0% | -531.8% | +112.6% | +855.6% | -238.2% | -9.4% |
| Profit margin | -95.0% | -56.4% | 513.0% | -80.1% | -67.1% | -134.0% | — | — | — | -66.0% | -57.2% | 2.1% | 11.5% | -17.4% | -28.4% |